Coeptis Therapeutics Warrants
COEPW
COEPW was delisted on the 24th of April, 2026.
21 hedge funds and large institutions have $272K invested in Coeptis Therapeutics Warrants in 2022 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 3 increasing their positions, 4 reducing their positions, and 8 closing their positions.
9% less funds holding
Funds holding: 23 → 21 (-2)
25% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 8
25% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 4
68% less capital invested
Capital invested by funds: $843K → $272K (-$571K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MC
Meteora Capital
Boca Raton,
Florida
|
+$19.5K |
| 2 |
Walleye Capital
New York
|
+$3.98K |
| 3 |
CL
CSS LLC
Chicago,
Illinois
|
+$3.84K |
| 4 |
WAM
Wolverine Asset Management
Chicago,
Illinois
|
+$2.25K |
| 5 |
VF
Virtu Financial
New York
|
+$1.38K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BCM
Basso Capital Management
Stamford,
Connecticut
|
-$15K |
| 2 |
OCAM
Owl Creek Asset Management
New York
|
-$6.68K |
| 3 |
CF
Cantor Fitzgerald
New York
|
-$3K |
| 4 |
PC
Periscope Capital
Toronto,
Ontario, Canada
|
-$3K |
| 5 |
SCM
Shaolin Capital Management
Miami,
Florida
|
-$3K |
COEPW Hedge Fund Activity: Q4 2022 in Review
21 of the 6,222 institutional investors tracked by Wall St. Rank reported a position in Coeptis Therapeutics Warrants (COEPW) for Q4 2022, worth a combined $272K — down 68% from $843K a quarter earlier.
Sellers outnumbered buyers: 8 funds closed out of COEPW and 6 opened new positions — a net loss of 2 holders — while 4 trimmed existing stakes and 3 added.
The largest buyer was Meteora Capital, opening a new position worth an estimated $19.5K. The largest seller was Basso Capital Management, exiting entirely with an estimated $15K sold.
- 21 institutional investors held Coeptis Therapeutics Warrants (COEPW) as of Q4 2022, down from 23 in Q3 2022.
- Funds reported $272K of Coeptis Therapeutics Warrants stock for Q4 2022, down 68% quarter-over-quarter.
- 6 funds opened new Coeptis Therapeutics Warrants positions in Q4 2022 and 8 closed out, a net change of -2 holders.
- The largest Coeptis Therapeutics Warrants buyer in Q4 2022 was Meteora Capital, an estimated $19.5K added.
- The largest Coeptis Therapeutics Warrants seller in Q4 2022 was Basso Capital Management, an estimated $15K sold.
Based on aggregated 13F filings for Q4 2022.